| Saleem A Khanani, MD | |
|
123 Summer St, Suite 385, Worcester, MA 01608 | |
| (508) 368-3168 | |
| (508) 368-3166 |
| Full Name | Saleem A Khanani |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 39 Years |
| Location | 123 Summer St, Worcester, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255306643 | NPI | - | NPPES |
| 5420027 | Other | US HEALTHCARE | |
| J16228 | Other | BLUE CARE ELECT | |
| 1050340 | Other | FIRST HEALTH | |
| 3133184 | Other | HEALTHY START | |
| 3000106 | Other | EVERCARE | |
| 784227 | Other | MVP HEALTH CARE | |
| 91688 | Other | FALLON COMM HEALTH PLAN | |
| AA2308 | Other | HARVARD PILGRIM HLTHCARE | |
| J16228 | Other | BLUE SHIELD HMO BLUE | |
| J16228 | Other | BLUE SHIELD INDEMNITY | |
| 042472266 | Other | ONE HEALTH PLAN | |
| 042472266 | Other | PRIVATE HEALTHCARE SYST | |
| 3133184 | Medicaid | MA | |
| 5420027 | Other | AETNA | |
| A20436 | Other | MEDICARE B | |
| 3133184 | Other | MEDICAID WELFARE | |
| 4207375 | Other | CIGNA HEALTH PLAN | |
| 042472266 | Other | HEALTHCARE VALUE MGMT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 79814 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Heywood Hospital - | Gardner, MA | Hospital |
| Athol Memorial Hospital | Athol, MA | Hospital |
| Umass Memorial Medical Center/university Campus | Worcester, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Henry Heywood Memorial Hospital | 1658262605 | 61 |
News Archive
Volleys of rhetoric, attack advertisements and procedural parries are echoing through Congress's health care debate. Here's a look at some of the latest political jabs.
A new blood test could increase the success of a popular lung cancer drug called erlotinib by allowing doctors select which patients will react positively to the drug.
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare announced that Bayer HealthCare has submitted an application for marketing authorization in Europe for VEGF Trap-Eye for the treatment of the neovascular form of age-related macular degeneration (wet AMD).
An unfortunate biological "feed-forward" loop drives cartilage cells in an arthritic joint to actually contribute to progression of the disease, say researchers at Duke University and Washington University in Saint Louis.
Aetna today announced that it has completed its acquisition of Prodigy Health Group, the nation's largest independent third party administrator (TPA) of self-funded health care plans.
› Verified 4 days ago
| Entity Name | Henry Heywood Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205823879 PECOS PAC ID: 1658262605 Enrollment ID: O20040322000360 |
News Archive
Volleys of rhetoric, attack advertisements and procedural parries are echoing through Congress's health care debate. Here's a look at some of the latest political jabs.
A new blood test could increase the success of a popular lung cancer drug called erlotinib by allowing doctors select which patients will react positively to the drug.
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare announced that Bayer HealthCare has submitted an application for marketing authorization in Europe for VEGF Trap-Eye for the treatment of the neovascular form of age-related macular degeneration (wet AMD).
An unfortunate biological "feed-forward" loop drives cartilage cells in an arthritic joint to actually contribute to progression of the disease, say researchers at Duke University and Washington University in Saint Louis.
Aetna today announced that it has completed its acquisition of Prodigy Health Group, the nation's largest independent third party administrator (TPA) of self-funded health care plans.
› Verified 4 days ago
| Entity Name | Athol Memorial Hospital Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336120047 PECOS PAC ID: 7911959846 Enrollment ID: O20050218000228 |
News Archive
Volleys of rhetoric, attack advertisements and procedural parries are echoing through Congress's health care debate. Here's a look at some of the latest political jabs.
A new blood test could increase the success of a popular lung cancer drug called erlotinib by allowing doctors select which patients will react positively to the drug.
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare announced that Bayer HealthCare has submitted an application for marketing authorization in Europe for VEGF Trap-Eye for the treatment of the neovascular form of age-related macular degeneration (wet AMD).
An unfortunate biological "feed-forward" loop drives cartilage cells in an arthritic joint to actually contribute to progression of the disease, say researchers at Duke University and Washington University in Saint Louis.
Aetna today announced that it has completed its acquisition of Prodigy Health Group, the nation's largest independent third party administrator (TPA) of self-funded health care plans.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Saleem A Khanani, MD 630 Plantation St, Worcester, MA 01605 Ph: (508) 368-3168 | Saleem A Khanani, MD 123 Summer St, Suite 385, Worcester, MA 01608 Ph: (508) 368-3168 |
News Archive
Volleys of rhetoric, attack advertisements and procedural parries are echoing through Congress's health care debate. Here's a look at some of the latest political jabs.
A new blood test could increase the success of a popular lung cancer drug called erlotinib by allowing doctors select which patients will react positively to the drug.
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare announced that Bayer HealthCare has submitted an application for marketing authorization in Europe for VEGF Trap-Eye for the treatment of the neovascular form of age-related macular degeneration (wet AMD).
An unfortunate biological "feed-forward" loop drives cartilage cells in an arthritic joint to actually contribute to progression of the disease, say researchers at Duke University and Washington University in Saint Louis.
Aetna today announced that it has completed its acquisition of Prodigy Health Group, the nation's largest independent third party administrator (TPA) of self-funded health care plans.
› Verified 4 days ago
Dr. Adepeju Gbadebo Champion, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 55 Lake Ave N, Worcester, MA 01655 Phone: 508-334-2731 Fax: 774-442-4672 | |
Madaiah Lokeshwari, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 123 Summer St, Worcester, MA 01608 Phone: 508-363-6849 | |
Sowmya Korapati, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 55 Lake Ave N, Worcester, MA 01655 Phone: 508-334-3550 Fax: 774-442-6715 | |
Irma Hashmi, DO Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 55 Lake Ave N, Worcester, MA 01655 Phone: 508-334-1000 | |
Dr. Madhav Sharma, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 123 Summer St, Worcester, MA 01608 Phone: 508-363-5438 | |
Daniel M Steigman, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 123 Summer Street, Suite 390, Worcester, MA 01608 Phone: 508-368-3120 Fax: 508-368-3121 | |
Dr. Julia D Andrieni, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 55 Lake Ave N, Department Of General Medicine, Worcester, MA 01655 Phone: 508-334-2731 |